2020
The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine
Farnum SO, Makarenko I, Madden L, Mazhnaya A, Marcus R, Prokhorova T, Bojko MJ, Rozanova J, Dvoriak S, Islam Z, Altice FL. The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine. Addiction 2020, 116: 83-93. PMID: 32428276, PMCID: PMC7674222, DOI: 10.1111/add.15115.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyOAT discontinuationAgonist therapyTreatment retentionIndependent predictorsHIV epidemicCost-effective HIV prevention strategyMethadone maintenance treatment patientsObservational longitudinal cohort studySpecialty addictions treatmentBuprenorphine maintenance treatmentHigh dosageHIV prevention strategiesLongitudinal cohort studyOpioid-dependent peopleTreatment discontinuationCohort studyMaintenance treatmentMale sexTreatment patientsPrevention strategiesDiscontinuationYounger ageCenter settingAddiction treatment
2016
Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy
Kutsa O, Marcus R, Bojko MJ, Zelenev A, Mazhnaya A, Dvoriak S, Filippovych S, Altice FL. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy. Journal Of The International AIDS Society 2016, 19: 20897. PMID: 27435717, PMCID: PMC4951533, DOI: 10.7448/ias.19.4.20897.Peer-Reviewed Original ResearchConceptsPolice violenceSexual violenceViolence experiencesHIV prevention strategiesCost-effective HIV prevention strategyMore physical violenceOpioid agonist therapyPolice harassmentLaw enforcementPhysical violenceViolencePoliceFrequent harassmentPWID's experiencesEastern EuropeSexual assaultOAT retentionUkrainian citiesOAT clientsCentral AsiaHIV prevalence ratesAgonist therapyFrequent experiencesRespondent-driven samplingHIV prevention